Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,477 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial.
Jönsson B, Cook JR, Pedersen TR. Jönsson B, et al. Diabetologia. 1999 Nov;42(11):1293-301. doi: 10.1007/s001250051441. Diabetologia. 1999. PMID: 10550412 Clinical Trial.
The economic cost of multiple sclerosis in Sweden in 1994.
Henriksson F, Jönsson B. Henriksson F, et al. Among authors: jonsson b. Pharmacoeconomics. 1998 May;13(5 Pt 2):597-606. doi: 10.2165/00019053-199813050-00012. Pharmacoeconomics. 1998. PMID: 17165326
The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial.
Lindgren P, Eriksson J, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT trial investigators. Lindgren P, et al. Among authors: jonsson b. Int J Clin Pract. 2010 Aug;64(9):1228-34. doi: 10.1111/j.1742-1241.2010.02445.x. Epub 2010 May 24. Int J Clin Pract. 2010. PMID: 20500533 Clinical Trial.
The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder.
Sobocki P, Ekman M, Ovanfors A, Khandker R, Jönsson B. Sobocki P, et al. Among authors: jonsson b. Int J Clin Pract. 2008 Apr;62(4):623-32. doi: 10.1111/j.1742-1241.2008.01711.x. Epub 2008 Feb 15. Int J Clin Pract. 2008. PMID: 18284439 Free PMC article. Clinical Trial.
The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments.
Kobelt G, Jönsson B. Kobelt G, et al. Among authors: jonsson b. Eur J Health Econ. 2008 Jan;8 Suppl 2:95-106. doi: 10.1007/s10198-007-0091-0. Eur J Health Econ. 2008. PMID: 18157559 Review.
Cost of illness in adult patients with hypopituitarism.
Ehrnborg C, Hakkaart-Van Roijen L, Jonsson B, Rutten FF, Bengtsson BA, Rosén T. Ehrnborg C, et al. Among authors: jonsson b. Pharmacoeconomics. 2000 Jun;17(6):621-8. doi: 10.2165/00019053-200017060-00008. Pharmacoeconomics. 2000. PMID: 10977399
Second International Pharmacoeconomic Conference on Alzheimer' s Disease.
Jönsson L, Jönsson B, Wimo A, Whitehouse P, Winblad B. Jönsson L, et al. Among authors: jonsson b. Alzheimer Dis Assoc Disord. 2000 Jul-Sep;14(3):137-40. doi: 10.1097/00002093-200007000-00004. Alzheimer Dis Assoc Disord. 2000. PMID: 10994654
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies.
Jönsson B, Kobelt G, Smolen J. Jönsson B, et al. Eur J Health Econ. 2008 Jan;8 Suppl 2:S61-86. doi: 10.1007/s10198-007-0089-7. Eur J Health Econ. 2008. PMID: 18097697
A global comparison regarding patient access to cancer drugs.
Jönsson B, Wilking N. Jönsson B, et al. Ann Oncol. 2007 Apr;18 Suppl 3:iii1-iii77. doi: 10.1093/annonc/mdm095. Ann Oncol. 2007. PMID: 17494969 No abstract available.
Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden.
Henriksson F, Fredrikson S, Masterman T, Jönsson B. Henriksson F, et al. Among authors: jonsson b. Eur J Neurol. 2001 Jan;8(1):27-35. doi: 10.1046/j.1468-1331.2001.00169.x. Eur J Neurol. 2001. PMID: 11509078
1,477 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback